Effect of Systemically Administered Azithromycin in Early Onset Aggressive Periodontitis

Fujii, Takeo; Pao-Li Wang; Hosokawa, Yoichiro; Shirai, Shinichi; Tamura, Atsumu; Hikita, Kazuhiro; Maida, Takeo; Ochi, Morio; Baehni, Pierre C.
September 2004
Periodontal Practice Today;2004, Vol. 1 Issue 4, p321
Academic Journal
Azithromycin is a macrolide which possesses a strong antimicrobial activity against Gram-positive and Gram-negative pathogens. In the present study, we studied the effect of azithromycin as an adjunct to non-surgical treatment in early onset aggressive periodontitis. Initial treatment consisting of oral instructions and full-mouth scaling and root planing was performed over a 2-month period. Patients were then administered with azithromycin, 500 mg per os, 1×/day, for 3 days. Professional mechanical tooth cleaning was performed once every two weeks during the initial preparation. Initial treatment was considered as completed when the gingival index was < 1. The probing pocket depth, percentage of periodontal pockets with depth ≥ 4 mm, and the rate of bleeding on probing improved following treatment. The duration of the treatment was 4.7 ± 3.2 months. Another group of patients received the same initial treatment but without azithromycin. The duration of the treatment for this group was 11.2 ± 4.9 months. These results indicate that azithromycin may be useful for the treatment of early onset periodontitis.


Related Articles

  • Synthesis and antimicrobial activity of Dihydropyrimidine derivatives. Mishra, Manish Kumar; Gupta, A. K.; Negi, S. // Drug Invention Today;Aug2010, Vol. 2 Issue 8, p387 

    6-methyl-2-oxo N-(4-oxo-2-substituted phenyl-1,3-thiazolidin-3-yl)-4-substituted phenyl-1,2,3,4-tetrahydropyrimidine-5-carboxamide have been synthesized and compound 4b and 4e has significant effect against Streptococcus aureus for gram positive and 4b and 4d has significant effect against...

  • Applying antimicrobial pharmacodynamics to resistant gram-negative pathogens. Scheetz, Marc H.; Hurt, Kristin M.; Noskin, Gary A.; Oliphant, Catherine M. // American Journal of Health-System Pharmacy;7/15/2006, Vol. 63 Issue 14, p1346 

    Purpose. Guided antibiotic adjustment for the treatment of multidrug-resistant, gram-negative pathogens is explored. Summary. Multidrug-resistant pathogens are being isolated with increasing frequency, while the production of novel agents to circumvent resistance has slowed to a near halt....

  • Distribution of Macrolide, Lincosamide, Streptogramin, Ketolide and Oxazolidinone (MLSKO) Resistance Genes in Gram-negative Bacteria. Roberts, Marilyn C. // Current Drug Targets - Infectious Disorders;Sep2004, Vol. 4 Issue 3, p207 

    A number of different mechanisms of macrolide resistance have been described in Gram-negative bacteria. These include 16 acquired genes (esterases, phosphorylases, rRNA methylases, and effluxes) and include those thought to be unique to Gram-negative bacteria (both esterases and two of the...

  • Efficacy of subantimicrobial dosing with doxycycline. Greenstein, Gary; Lamster, Ira // Journal of the American Dental Association (JADA);Apr2001, Vol. 132 Issue 4, p457 

    Addresses the role of subantimicrobial dosing with doxycycline or SDD, in the treatment of chronic periodontitis. Enhancement of the efficacy of scaling and root planing; Most accurate way to express the degree of improvement in probing depth reduction; Clinical attachment that can be gained...

  • Antimicrobial susceptibility pattern of bacterial isolates from surgical wound infections in Tertiary Care Hospital in Allahabad, India. Verma, Amit Kumar; Kapoor, A. K.; Bhargava, Anodita // Internet Journal of Medical Update;Jan2012, Vol. 7 Issue 1, p27 

    The aim of present study to analyze the occurrence and in-vitro antimicrobial susceptibility of bacterial pathogens isolated from surgical wound infections. Specimens from a total of 129 patients undergoing either emergency or elective surgery were collected from infected sites or stitch lines...

  • Challenges in Identifying New Antimicrobial Agents Effective for Treating Infections with Acinetobacter baumannii and Pseudomonas aeruginosa. Rice, Louis B. // Clinical Infectious Diseases;9/1/2006 Supplement, Vol. 43, pS100 

    Acinetobacter baumannii and Pseudomonas aeruginosa are gram-negative pathogens that target immunocompromised patients. They express a variety of determinants that confer resistance to a broad array of antimicrobial agents. Mechanisms of resistance include impaired entry through the bacterial...

  • Azithromycin Extended Release: A Review of its Use in the Treatment of Acute Bacterial Sinusitis and Community-Acquired Pneumonia in the US. Swainston, Tracy; Kean, Susan J. // Drugs;2007, Vol. 67 Issue 5, p773 

    Azithromycin is a macrolide antibacterial agent. The novel microspheres oral extended-release formulation (Zmaxâ„¢) is the first antibacterial drug approved in the US for administration as a single dose in adult patients with mild to moderate acute bacterial sinusitis (ABS) or...

  • In Vitro Activity of Doripenem. Sahm, Daniel // Clinical Infectious Diseases;Aug2009 Supplement 1, Vol. 49, pS11 

    Doripenem is a carbapenem antibiotic that covers a wide range of gram-positive and gram-negative pathogens. In vitro studies have provided insight into certain features of doripenem's activity profile that may have particular relevance in the clinical setting. For instance, in vitro data...

  • Peritonitis More Likely to Recur with S. aureus.  // Kidney;Mar/Apr99, Vol. 8 Issue 2, p74 

    Presents an abstract of the study 'Differing outcomes of gram-positive and gram-negative peritonitis,' by L. Troidle, N. Gorban-Brennan, A. Kliger, et al.


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics